Dr. Maia Kirsten Keller, MD Dermatology Medicare: Medicare Enrolled Practice Location: 1415 Woodland Ave Ste 140, Des Moines, IA 50309 Phone: 515-241-8595 Fax: 515-241-4080 |
Dr. John William Holtze, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1221 Pleasant St, Ste 500, Des Moines, IA 50309 Phone: 515-241-8660 Fax: 515-241-8662 |
Dr. Britt K Deruyter, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 1801 Hickman Rd, Des Moines, IA 50314 Phone: 515-282-5640 Fax: 515-282-2332 |
Dr. Mirza Baig, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3520 Beaver Ave, Suite G, Des Moines, IA 50310 Phone: 515-277-3455 |
Jeffrey Dobrzynski, MD Dermatology Medicare: Medicare Enrolled Practice Location: 1415 Woodland Ave Ste 140, Des Moines, IA 50309 Phone: 515-241-8595 |
News Archive
Injecting the eye with the corticosteroid triamcinolone appears effective in improving the vision of some patients with retinal vein occlusion, an important cause of vision loss that results from blockages in the blood vessels in the retina, according to two reports in the September issue of Archives of Ophthalmology, one of the JAMA/Archives journals.
According to a study conducted at Thomas Jefferson University (TJU), non-invasive coronary computed tomography angiography (CTA) is a cost-effective alternative to invasive cardiac catheterization in the care of patients who have positive stress test results but a less than 50 percent chance of actually having significant coronary artery disease (CAD). The study will be published in the May issue of the American Journal of Roentgenology.
A new study from British researchers has revealed that sleep does not improve memory in an eyewitness. The study titled, "The impact of sleep on eyewitness identifications," was published in the latest issue of the journal Royal Society Open Science on the 4th of December 2019.
Vitrolife has received approval from the U.S. Food and Drug Administration, FDA, the equivalent of the Swedish Medical Products Agency, for the products RapitVit™ Blast and RapidWarm™ Blast. So-called 510(k) clearance has been obtained for these products, which are used for so-called vitrification, the rapid freezing and thawing of blastocysts (embryos days 5-7 after fertilization). Vitrolife has since before approved products for vitrification of embryos in an earlier stage of the fertilization (embryos day 2-3 after fertilization).
Epileptic spasms are a type of brief seizures that are the hallmark of catastrophic seizure disorders, which are characterized by severe cognitive and motor deficits.
› Verified 8 days ago